Journal of Clinical and Cellular Immunology
Open Access
ISSN: 2155-9899
+44 1223 790975
ISSN: 2155-9899
+44 1223 790975
Mads Hald Andersen
Department of Hematology, Center for Cancer Immune Therapy, 54P4, Copenhagen University Hospital, Herlev, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
Professor Mads Hald Andersen has just been honored with the Lundbeck Foundation Young Scientist Award, which is awarded to a particularly promising researchers under 40 who have achieved excellent health or scientific research. He had pointed vice-director of CCIT when the centre was established in October 2006. He graduated as M.Sc.Eng. from the Technical University of Denmark (DTU) in 1998. He holds a PhD degree from DTU (2001) and a doctorate in technology (dr. techn; 2006) from the same University. In 2009 he was appointed Honorary Professor at DTU. Before joining CCIT he was Senior Scientist at the Tumor Immunology group at the Danish Cancer Society as well as at the Department of Dermatology, Würzburg University, Germany. In addition, he has founded several minor biotech companies (including SurVac in 2003) and has functioned as scientific advisor in biotech as well as Pharmacy companies.
His research interests include the characterization of novel tumor antigens, derived from proteins playing an important role for tumor cell growth and/or survival to avoid the selection of antigen-negative tumor cells during immunotherapy; the monitoring and description of T-cell responses in cancer patients both in preclinical and clinical settings.